Breast Cancer Clinical Trials in Baltimore

Showing 621-640 of 691 trials

To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older

NCT00082095

The main purpose of this study is to compare treatment with either pegylated liposomal doxorubicin or capecitabine as first line chemotherapy for metastatic breast cancer in women 60 years and older.

Metastatic Breast Cancer

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.62 participantsStarted Apr 2004

Fountain Valley, California, United States • Oxnard, California, United States • Soquel, California, United States +24 more locations

COMPLETEDPhase 3< 1 mile

Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer

NCT00320710

Clinical trial in breast cancer patients with bone metastases pretreated for approximately 1 year with a standard zoledronic acid regimen. Looking at the continued effectiveness and safety of giving zoledronic acid every 4 weeks versus every 12 weeks given over 1 year. This study is prospective, double-blind, stratified, multi-center, and two-arm.

Breast Cancer

Novartis Pharmaceuticals416 participantsStarted Feb 2006

Anchorage, Alaska, United States • Hot Springs, Arkansas, United States • Springdale, Arkansas, United States +89 more locations

To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older

Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer

Breast Cancer Trials in Other Cities

MarginProbe, a Device for Intraoperative Assessment of Margin Status in Breast Conservation Surgery

Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer

Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer

Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer

Regional Anesthesia Versus General Anesthesia on Circulating Tumor Cells (CTC)

Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer

Letrozole, Herceptin in Her2neu +, Estrogen Receptor [ER] and/or Progesterone Receptor [PR] Positive, MBC

1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy

Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer

Nutrition Intervention in Treating Women With Breast Cancer

Combination of Oral WX-671 Plus Capecitabine vs. Capecitabine Monotherapy in First-line Her2-negative Metastatic Breast Cancer

Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI)

Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer

A Study of Trastuzumab Emtansine (T-DM1) Sequentially With Anthracycline-based Chemotherapy, as Adjuvant or Neoadjuvant Therapy for Patients With Early Stage Herceptin (HER)2-positive Breast Cancer

Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification

STRIDE - STimulating Immune Response In aDvanced brEast Cancer

OctavaPink for Women With Dense Breast After Negative Mammography

A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)

Other Conditions in Baltimore